2025 Q4 -tulosraportti
Vain PDF
52 päivää sitten
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·30.3. · MuokattuI wonder if we'll get some news before Easter? I have a slight feeling... - Unless the busy people have already gone on Easter holiday 🥳 Meanwhile, investors can watch their investment become worth less and less 📉 The price is far from the 1000kr at IPO in 2021 (it was 10kr back then before the reverse split).
·19.3.Has Tine Kold gone Kold? I really don't think much is happening and hasn't been for a long time. What do people think is the reason for this? Why aren't they producing their product so they can get started again?
·16.2.The Q4-25 report shows that there is liquidity probably until Q1-26. So now. 15 mill SEK. They used 12.5 mill in Q4-25, but also 4 mill for cohort 3. So cash is tight. They write cash flow -7.5 mill so for two quarters, but that is with an increase in debt of 4 mill. and it's not credible they can increase debt right now unless it's public loans. So I think it's now that a share issue will come.
·17.3.It's also not a company that discloses much! It gets pretty tedious, damn it·19.3.I completely agree with everything you write. I also think it's plausible to believe that there will be another share issue with news about the 3rd Cohort. But with the history Biosergen has with share issues - why would one then believe that this one would be the last? That's kind of where I am. I can handle a single share issue, as I don't have a loss yet, (sold out just before the news about the last share issue) but with several share issues and several possible delays, the case is just not that attractive.- ·10.2.What is your assessment of the report?
·15.2.Bongo111 You are right. One should be careful with chatgpt, as one does not always get the same answer for the same search. 1. cohort was completed October 24, while 2. cohort was completed in February 25. The 3. cohort is thus delayed due to the preparation of a new batch. It has taken a year to get it in place, but I agree with you that a more efficient production must be planned for the much larger quantities for use in phase II/III. - ·3.2.Weak selling side. It is rising, however, on relatively low volume. It can move quickly from here with the right news 📈 If they, for example, announce that the last cohort will soon begin or that they have secured financing. If, on the other hand, they announce an issuance or that we have to wait a considerable amount of time yet before the cohort begins, it will probably hurt 📉
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
52 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·30.3. · MuokattuI wonder if we'll get some news before Easter? I have a slight feeling... - Unless the busy people have already gone on Easter holiday 🥳 Meanwhile, investors can watch their investment become worth less and less 📉 The price is far from the 1000kr at IPO in 2021 (it was 10kr back then before the reverse split).
- ·19.3.Has Tine Kold gone Kold? I really don't think much is happening and hasn't been for a long time. What do people think is the reason for this? Why aren't they producing their product so they can get started again?
- ·16.2.The Q4-25 report shows that there is liquidity probably until Q1-26. So now. 15 mill SEK. They used 12.5 mill in Q4-25, but also 4 mill for cohort 3. So cash is tight. They write cash flow -7.5 mill so for two quarters, but that is with an increase in debt of 4 mill. and it's not credible they can increase debt right now unless it's public loans. So I think it's now that a share issue will come.·17.3.It's also not a company that discloses much! It gets pretty tedious, damn it·19.3.I completely agree with everything you write. I also think it's plausible to believe that there will be another share issue with news about the 3rd Cohort. But with the history Biosergen has with share issues - why would one then believe that this one would be the last? That's kind of where I am. I can handle a single share issue, as I don't have a loss yet, (sold out just before the news about the last share issue) but with several share issues and several possible delays, the case is just not that attractive.
- ·10.2.What is your assessment of the report?·15.2.Bongo111 You are right. One should be careful with chatgpt, as one does not always get the same answer for the same search. 1. cohort was completed October 24, while 2. cohort was completed in February 25. The 3. cohort is thus delayed due to the preparation of a new batch. It has taken a year to get it in place, but I agree with you that a more efficient production must be planned for the much larger quantities for use in phase II/III.
- ·3.2.Weak selling side. It is rising, however, on relatively low volume. It can move quickly from here with the right news 📈 If they, for example, announce that the last cohort will soon begin or that they have secured financing. If, on the other hand, they announce an issuance or that we have to wait a considerable amount of time yet before the cohort begins, it will probably hurt 📉
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
2025 Q4 -tulosraportti
Vain PDF
52 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 20.8.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·30.3. · MuokattuI wonder if we'll get some news before Easter? I have a slight feeling... - Unless the busy people have already gone on Easter holiday 🥳 Meanwhile, investors can watch their investment become worth less and less 📉 The price is far from the 1000kr at IPO in 2021 (it was 10kr back then before the reverse split).
- ·19.3.Has Tine Kold gone Kold? I really don't think much is happening and hasn't been for a long time. What do people think is the reason for this? Why aren't they producing their product so they can get started again?
- ·16.2.The Q4-25 report shows that there is liquidity probably until Q1-26. So now. 15 mill SEK. They used 12.5 mill in Q4-25, but also 4 mill for cohort 3. So cash is tight. They write cash flow -7.5 mill so for two quarters, but that is with an increase in debt of 4 mill. and it's not credible they can increase debt right now unless it's public loans. So I think it's now that a share issue will come.·17.3.It's also not a company that discloses much! It gets pretty tedious, damn it·19.3.I completely agree with everything you write. I also think it's plausible to believe that there will be another share issue with news about the 3rd Cohort. But with the history Biosergen has with share issues - why would one then believe that this one would be the last? That's kind of where I am. I can handle a single share issue, as I don't have a loss yet, (sold out just before the news about the last share issue) but with several share issues and several possible delays, the case is just not that attractive.
- ·10.2.What is your assessment of the report?·15.2.Bongo111 You are right. One should be careful with chatgpt, as one does not always get the same answer for the same search. 1. cohort was completed October 24, while 2. cohort was completed in February 25. The 3. cohort is thus delayed due to the preparation of a new batch. It has taken a year to get it in place, but I agree with you that a more efficient production must be planned for the much larger quantities for use in phase II/III.
- ·3.2.Weak selling side. It is rising, however, on relatively low volume. It can move quickly from here with the right news 📈 If they, for example, announce that the last cohort will soon begin or that they have secured financing. If, on the other hand, they announce an issuance or that we have to wait a considerable amount of time yet before the cohort begins, it will probably hurt 📉
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt